| Operating Activities: | |
| Net income | 73.98M |
| Adjustments to reconcile net income to net cash provided by operating activities: | |
| Depreciation, amortization and accretion | 18.76M |
| Stock-based compensation | 2.55M |
| (Decrease) increase in allowance for returns - net of inventory in transit | -238K |
| Loss on disposal of assets | 266K |
| Impairment losses | |
| Equity in loss (income) of joint venture | |
| Distribution from joint venture | |
| Decrease in allowance for doubtful accounts | |
| Excess tax benefits from stock-based compensation | -4.08M |
| Deferred income taxes and other | |
| Changes in operating assets and liabilities: | |
| Accounts receivable | 99.4M |
| Inventories | -11.51M |
| Prepaid expenses and other current assets | -14.72M |
| Accounts payable | -20.37M |
| Accrued expenses | -49M |
| Income taxes payable | -6.81M |
| Net cash provided by operating activities | |
| Investing Activities: | |
| Additions to property, plant and equipment | -19.49M |
| Increase in intangible and other assets | -723K |
| Purchase of securities available for sale | |
| Sales/maturities of securities available for sale | |
| Proceeds from the sale of property, plant and equipment | |
| Net cash used in investing activities | |
| Financing Activities: | |
| Acquisition of common stock | -61.19M |
| Distribution of noncontrolling interest earnings | -4K |
| Excess tax benefits from stock-based compensation | 4.08M |
| Borrowings on notes payable | 218.1M |
| Payments on notes payable | -142.72M |
| Proceeds from exercise of stock options | 1.99M |
| Net cash used in financing activities | |
| Effect of exchange rate changes on cash and cash equivalents | |
| Net (decrease) increase in cash and cash equivalents | |
| Cash and cash equivalents: | |
| Beginning of period | 177.24M |
| End of period | 241.4M |